Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metazoa is an early-stage life science technology company developing miniaturized, skin-compliant biosensors for small-animal monitoring in preclinical research. The company is focused on a non-invasive, wireless system for collecting mouse electrocardiography and locomotion data, with the goal of simplifying physiology studies while improving animal welfare and data quality. Its technology appears to combine flexible electronics, advanced materials science, and wearable biosensing approaches adapted for laboratory animals. Rather than developing therapeutics, Metazoa is best characterized as a research tools and device platform company serving preclinical scientists and physiologists.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metazoa.